Pediatric sublingual allergen immunotherapy

被引:5
|
作者
Blaiss, Michael S. [1 ]
机构
[1] Augusta Univ, Med Coll Georgia, Dept Pediat, Augusta, GA USA
关键词
MITE-SENSITIZED CHILDREN; DOUBLE-BLIND; ATOPIC-DERMATITIS; EAACI GUIDELINES; EFFICACY; SAFETY; RHINITIS; RHINOCONJUNCTIVITIS; ASTHMA;
D O I
10.2500/aap.2022.43.210079
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Sublingual immunotherapy (SLIT) offers an important therapeutic modality in the management of children with respiratory allergies. Along with subcutaneous immunotherapy, these modalities are the only selections that have shown not merely relief of symptoms but also disease-modifying activity. SLIT can be given as either a dissolvable tablet (SLIT-T) or liquid drops (SLIT-D). In studies that examined the efficacy and safety in allergic rhinitis and asthma, SLIT-T and SLIT-D both show efficacy in reducing symptoms and the need for medication, although it seems that SLIT-T may show a better response. Almost all SLIT-D efficacy studies are with single allergens. There are virtually no data on the efficacy of mixing unrelated allergens in the same prescription. Both SLIT-T and SLIT-D treatments are safe, with the most common adverse effects being local ones, such as oral pruritus and mouth irritation, which tend to be mild and short lived. Studies that assess the role of SLIT in the prevention of new sensitizations and asthma in the pediatric population are insufficient and of mixed results; therefore, no conclusions can be made. In the treatment of other pediatric conditions, such as food allergy and atopic dermatitis, there are few studies that assessed if, and the degree of, the benefit with SLIT. In determining if SLIT should be prescribed for the pediatric patient, there is a need for shared decision-making to allow the older child and parents or caregivers to understand the pros and cons, and the costs of all the options and relate their values and preferences to the physician.
引用
收藏
页码:281 / 285
页数:5
相关论文
共 50 条
  • [31] Role of IL-35 in sublingual allergen immunotherapy
    Layhadi, Janice A.
    Eguiluz-Gracia, Ibon
    Shamji, Mohamed H.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 19 (01) : 12 - 17
  • [32] Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation
    Razafindratsita, Alain
    Saint-Lu, Nathalie
    Mascarell, Laurent
    Berjont, Nathalie
    Bardon, Thierry
    Betbeder, Didier
    Van Overtvelt, Laurence
    Moingeon, Philippe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (02) : 278 - 285
  • [33] Compliance in subcutaneous and sublingual allergen immunotherapy: A nationwide study
    Borg, Morten
    Lokke, Anders
    Hilberg, Ole
    RESPIRATORY MEDICINE, 2020, 170
  • [34] Sublingual allergen immunotherapy for respiratory allergies: what is new?
    Makatsori, Melina
    Calderon, Moises A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (12) : 1641 - 1647
  • [35] Economic evaluation of sublingual vs subcutaneous allergen immunotherapy
    Pokladnikova, Jitka
    Krcmova, Irena
    Vlcek, Jiri
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (05) : 482 - 489
  • [36] Allergen sublingual immunotherapy adherence-keys to improvement
    Seve, E.
    Trinh, H. B.
    Pouliquen, M.
    Cottet, J.
    Fromentin, E.
    Lefevre, S.
    Fontaine, J. F.
    Demoly, P.
    REVUE FRANCAISE D ALLERGOLOGIE, 2021, 61 (01): : 19 - 23
  • [37] Immunological mechanisms of sublingual allergen-specific immunotherapy
    Novak, N.
    Bieber, T.
    Allam, J-P
    ALLERGY, 2011, 66 (06) : 733 - 739
  • [38] Allergen-specific sublingual immunotherapy for respiratory allergy
    Passalacqua, G
    Canonica, GW
    BIODRUGS, 2001, 15 (08) : 509 - 519
  • [39] Enhancing Allergen-Presentation Platforms for Sublingual Immunotherapy
    Moingeon, P.
    Lombardi, V.
    Baron-Bodo, V.
    Mascarell, L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (01): : 23 - 31
  • [40] Pediatric subcutaneous allergen immunotherapy
    Parashar, Sonya
    Pandya, Aarti
    Portnoy, Jay M.
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (04) : 286 - 291